| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3708309
[patent_doc_number] => 05654420
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-05
[patent_title] => 'Process for preparing 2\'-cyano pyrimidine nucleoside compounds'
[patent_app_type] => 1
[patent_app_number] => 8/457510
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14951
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/654/05654420.pdf
[firstpage_image] =>[orig_patent_app_number] => 457510
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/457510 | Process for preparing 2'-cyano pyrimidine nucleoside compounds | May 31, 1995 | Issued |
Array
(
[id] => 3493438
[patent_doc_number] => 05561120
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-01
[patent_title] => 'Method for treating HBV infections with L-2\',3\'-didehydro-dideoxy-5-fluorocytidine'
[patent_app_type] => 1
[patent_app_number] => 8/456635
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 11
[patent_no_of_words] => 9926
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/561/05561120.pdf
[firstpage_image] =>[orig_patent_app_number] => 456635
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/456635 | Method for treating HBV infections with L-2',3'-didehydro-dideoxy-5-fluorocytidine | May 31, 1995 | Issued |
| 08/457914 | STABILIZED DISPERSIONS OF MISOPROSTOL | May 31, 1995 | Abandoned |
Array
(
[id] => 3659665
[patent_doc_number] => 05659025
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-19
[patent_title] => '3\'-(2\')-amino or thiol-modified, fluorescent dye-coupled oligonucleotides and a process for the preparation and the use thereof'
[patent_app_type] => 1
[patent_app_number] => 8/457377
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6316
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/659/05659025.pdf
[firstpage_image] =>[orig_patent_app_number] => 457377
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/457377 | 3'-(2')-amino or thiol-modified, fluorescent dye-coupled oligonucleotides and a process for the preparation and the use thereof | May 31, 1995 | Issued |
Array
(
[id] => 3876875
[patent_doc_number] => 05747472
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Therapeutic methods for using ARA-G derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/456186
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20017
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747472.pdf
[firstpage_image] =>[orig_patent_app_number] => 456186
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/456186 | Therapeutic methods for using ARA-G derivatives | May 30, 1995 | Issued |
Array
(
[id] => 3663029
[patent_doc_number] => 05648473
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-15
[patent_title] => '2\'-deoxy-2\', 2\'-difluoropyrimidine nucleosides and 2\'-deoxy-2\'-fluoropyrimidine nucleosides and intermediates'
[patent_app_type] => 1
[patent_app_number] => 8/454447
[patent_app_country] => US
[patent_app_date] => 1995-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8147
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/648/05648473.pdf
[firstpage_image] =>[orig_patent_app_number] => 454447
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/454447 | 2'-deoxy-2', 2'-difluoropyrimidine nucleosides and 2'-deoxy-2'-fluoropyrimidine nucleosides and intermediates | May 29, 1995 | Issued |
Array
(
[id] => 3767031
[patent_doc_number] => 05849504
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Nucleic acid probes and methods for detecting Pneumocystis carinii'
[patent_app_type] => 1
[patent_app_number] => 8/452145
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2343
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849504.pdf
[firstpage_image] =>[orig_patent_app_number] => 452145
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/452145 | Nucleic acid probes and methods for detecting Pneumocystis carinii | May 25, 1995 | Issued |
Array
(
[id] => 4060095
[patent_doc_number] => 05864033
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-26
[patent_title] => 'Adenosine kinase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/451236
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 29276
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/864/05864033.pdf
[firstpage_image] =>[orig_patent_app_number] => 451236
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/451236 | Adenosine kinase inhibitors | May 25, 1995 | Issued |
Array
(
[id] => 3783287
[patent_doc_number] => 05821236
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'Tumor treatment with arabinofuranosyl purine derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/449078
[patent_app_country] => US
[patent_app_date] => 1995-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19998
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821236.pdf
[firstpage_image] =>[orig_patent_app_number] => 449078
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/449078 | Tumor treatment with arabinofuranosyl purine derivatives | May 23, 1995 | Issued |
| 08/448632 | METHODS AND COMPOUNDS FOR THE STEREOSELECTIVE ENRICHMENT OF OLIGONUCLEOTIDE DIASTEREOMERS AND OLIGONUCLEOTIDES THEREBY PRODUCED | May 22, 1995 | Abandoned |
| 08/447384 | METHODS AND COMPOUNDS FOR THE STEROSELECTIVE ENRICHMENT OF OLIGONU- CLEOTIDE DIASTEREOMERS AND OLIGONUCLEOTIDES THEREBY PRODUCED | May 22, 1995 | Abandoned |
Array
(
[id] => 3898093
[patent_doc_number] => 05750674
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-12
[patent_title] => 'Methods and compounds for the stereoselective enrichment of oligonucleotide diastereomers and oligonucleotides thereby produced'
[patent_app_type] => 1
[patent_app_number] => 8/448131
[patent_app_country] => US
[patent_app_date] => 1995-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7904
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/750/05750674.pdf
[firstpage_image] =>[orig_patent_app_number] => 448131
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/448131 | Methods and compounds for the stereoselective enrichment of oligonucleotide diastereomers and oligonucleotides thereby produced | May 22, 1995 | Issued |
Array
(
[id] => 3775215
[patent_doc_number] => 05817640
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-06
[patent_title] => 'Methods of preventing tissue damage associated with decreased blood flow by administration of AICA riboside compounds'
[patent_app_type] => 1
[patent_app_number] => 8/443245
[patent_app_country] => US
[patent_app_date] => 1995-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 13359
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/817/05817640.pdf
[firstpage_image] =>[orig_patent_app_number] => 443245
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/443245 | Methods of preventing tissue damage associated with decreased blood flow by administration of AICA riboside compounds | May 15, 1995 | Issued |
Array
(
[id] => 3828597
[patent_doc_number] => 05783679
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-21
[patent_title] => 'Purine nucleoside modifications by palladium catalyzed methods and oligonucleotides containing same'
[patent_app_type] => 1
[patent_app_number] => 8/441881
[patent_app_country] => US
[patent_app_date] => 1995-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4656
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/783/05783679.pdf
[firstpage_image] =>[orig_patent_app_number] => 441881
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/441881 | Purine nucleoside modifications by palladium catalyzed methods and oligonucleotides containing same | May 15, 1995 | Issued |
Array
(
[id] => 3496234
[patent_doc_number] => 05508393
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-04-16
[patent_title] => 'Process for the preparation of ribonucleotide reductase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/439536
[patent_app_country] => US
[patent_app_date] => 1995-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9804
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/508/05508393.pdf
[firstpage_image] =>[orig_patent_app_number] => 439536
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/439536 | Process for the preparation of ribonucleotide reductase inhibitors | May 10, 1995 | Issued |
Array
(
[id] => 3659038
[patent_doc_number] => 05623069
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-22
[patent_title] => 'Method for producing 5\'-nucleotide'
[patent_app_type] => 1
[patent_app_number] => 8/437984
[patent_app_country] => US
[patent_app_date] => 1995-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3086
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/623/05623069.pdf
[firstpage_image] =>[orig_patent_app_number] => 437984
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/437984 | Method for producing 5'-nucleotide | May 9, 1995 | Issued |
Array
(
[id] => 3636344
[patent_doc_number] => 05631362
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-20
[patent_title] => '5\'-O-Dans EOC modified nucleosides and methods for preparing same'
[patent_app_type] => 1
[patent_app_number] => 8/437566
[patent_app_country] => US
[patent_app_date] => 1995-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7181
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/631/05631362.pdf
[firstpage_image] =>[orig_patent_app_number] => 437566
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/437566 | 5'-O-Dans EOC modified nucleosides and methods for preparing same | May 8, 1995 | Issued |
Array
(
[id] => 3790187
[patent_doc_number] => 05840881
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility'
[patent_app_type] => 1
[patent_app_number] => 8/437227
[patent_app_country] => US
[patent_app_date] => 1995-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12912
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840881.pdf
[firstpage_image] =>[orig_patent_app_number] => 437227
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/437227 | Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility | May 7, 1995 | Issued |
Array
(
[id] => 3657181
[patent_doc_number] => 05624597
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-29
[patent_title] => 'Reagent compositions for analytical testing'
[patent_app_type] => 1
[patent_app_number] => 8/436670
[patent_app_country] => US
[patent_app_date] => 1995-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6431
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/624/05624597.pdf
[firstpage_image] =>[orig_patent_app_number] => 436670
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/436670 | Reagent compositions for analytical testing | May 7, 1995 | Issued |
| 08/431595 | INTERMEDIATE IN PROCESS TO MAKE 2', 2'-DIFLOURONUCLEOSIDES | Apr 30, 1995 | Abandoned |